Abgenix Inc

Article Abstract:

The effectivity of Abgenix Inc.'s monoclonal antibody is being tested and the company has a lot riding on this product which seeks to inhibiting blood vessel growth around certain cancerous tumors. Stock is best held in a well-diversified portfolio.

Author: Clark, Charles
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Product information, Pharmaceutical industry, Abgenix Inc., ABGX

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Healthcare information services

Article Abstract:

The healthcare information services industry declined an average of 5.5% overall because of less money being invested on information systems. Stocks are to be considered by investors willing to consider uncertainties in the industry.

Author: Clark, Charles
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
History, Health care information services, Industry forecasts, Medical advice systems

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Cerner Corp

Article Abstract:

Cerner Corp.'s earnings growth in clinical information systems should contiue in 2003 and 2004 but are likely to remain ill-supported by cash flow. Investors are advised not to enter into new commitments for now.

Author: Clark, Charles
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Computer industry, Microcomputer industry, Cerner Corp., CERN

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Finance, Company investment, Investments, Statistics, Securities, Company sales and earnings, Company earnings/profit, Company securities, Company business forecast/projection, Company forecasts
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.